CFA
SBIO icon

Carroll Financial Associates’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Carroll Financial Associates’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-200
Closed -$9K – 1888
2021
Q3 		$9K Hold
200
– – ﹤0.01% 1257
2021
Q2 		$9K Hold
200
– – ﹤0.01% 1325
2021
Q1 		$10K Buy
+200
New +$11.1K ﹤0.01% 1221

Other funds holding SBIO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
MC
Matisse Capital Portland, Oregon $250M AUM 26.81% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $1.02B AUM 31.16% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Carroll Financial Associates's SBIO Position: Q4 2021 in Review

Carroll Financial Associates sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q4 2021, closing a stake of 200 shares — an estimated $9K sold.

Carroll Financial Associates first reported a position in SBIO in Q1 2021 and held it in 3 quarters. The position peaked at $10K in Q1 2021. 66 funds tracked by Wall St. Rank hold SBIO as of Q4 2021.

  • Carroll Financial Associates reported no remaining ALPS Medical Breakthroughs ETF position as of Q4 2021 after selling out during the quarter.
  • Carroll Financial Associates sold 200 ALPS Medical Breakthroughs ETF shares in Q4 2021, an estimated $9K.
  • Carroll Financial Associates first reported a position in ALPS Medical Breakthroughs ETF in Q1 2021 and held it in 3 quarters.
  • Carroll Financial Associates's ALPS Medical Breakthroughs ETF position peaked at $10K in Q1 2021.
  • 66 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.